These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31147807)

  • 21. Chemical Inhibition of Pre-mRNA Splicing in Living Saccharomyces cerevisiae.
    Hansen SR; Nikolai BJ; Spreacker PJ; Carrocci TJ; Hoskins AA
    Cell Chem Biol; 2019 Mar; 26(3):443-448.e3. PubMed ID: 30639260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-Tumor Effect of Rigosertib on HEL and K562 Cells and Its Related Mechanism].
    Xu F; Chang CK; Li X; He Q; Wu LY; Zhang Z
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1362-1366. PubMed ID: 29070108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug.
    Alors-Perez E; Blázquez-Encinas R; Alcalá S; Viyuela-García C; Pedraza-Arevalo S; Herrero-Aguayo V; Jiménez-Vacas JM; Mafficini A; Sánchez-Frías ME; Cano MT; Abollo-Jiménez F; Marín-Sanz JA; Cabezas-Sainz P; Lawlor RT; Luchini C; Sánchez L; Sánchez-Hidalgo JM; Ventura S; Martin-Hijano L; Gahete MD; Scarpa A; Arjona-Sánchez Á; Ibáñez-Costa A; Sainz B; Luque RM; Castaño JP
    J Exp Clin Cancer Res; 2021 Dec; 40(1):382. PubMed ID: 34857016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts.
    Janusz K; Del Rey M; Abáigar M; Collado R; Ivars D; Hernández-Sánchez M; Valiente A; Robledo C; Benito R; Díez-Campelo M; Ramos F; Kohlmann A; Cañizo CD; Hernández-Rivas JM
    Leuk Res; 2017 May; 56():82-87. PubMed ID: 28222336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splicing factor mutant myelodysplastic syndromes: Recent advances.
    Pellagatti A; Boultwood J
    Adv Biol Regul; 2020 Jan; 75():100655. PubMed ID: 31558432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of RNA splicing associated with Wnt signaling pathway using FD-895 and pladienolide B.
    Kumar D; Kashyap MK; Yu Z; Spaanderman I; Villa R; Kipps TJ; La Clair JJ; Burkart MD; Castro JE
    Aging (Albany NY); 2022 Mar; 14(5):2081-2100. PubMed ID: 35230971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel synthesized 3', 5'-diprenylated chalcone mediates the proliferation of human leukemia cells by regulating apoptosis and autophagy pathways.
    Zhang YQ; Wen ZH; Wan K; Yuan D; Zeng X; Liang G; Zhu J; Xu B; Luo H
    Biomed Pharmacother; 2018 Oct; 106():794-804. PubMed ID: 29990873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of apoptosis and cell cycle arrest by Bis (2-ethylhexyl) phthalate produced by marine Bacillus pumilus MB 40.
    Moushumi Priya A; Jayachandran S
    Chem Biol Interact; 2012 Jan; 195(2):133-43. PubMed ID: 22155658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Splicing Factor Mutations in Cancer.
    Bejar R
    Adv Exp Med Biol; 2016; 907():215-28. PubMed ID: 27256388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status.
    Suda K; Rozeboom L; Yu H; Ellison K; Rivard CJ; Mitsudomi T; Hirsch FR
    PLoS One; 2017; 12(2):e0172209. PubMed ID: 28192473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SF3B1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1 splicing and mTOR/ß-catenin pathways imbalances.
    Fuentes-Fayos AC; Pérez-Gómez JM; G-García ME; Jiménez-Vacas JM; Blanco-Acevedo C; Sánchez-Sánchez R; Solivera J; Breunig JJ; Gahete MD; Castaño JP; Luque RM
    J Exp Clin Cancer Res; 2022 Jan; 41(1):39. PubMed ID: 35086552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The spliceosome inhibitors isoginkgetin and pladienolide B induce ATF3-dependent cell death.
    Vanzyl EJ; Sayed H; Blackmore AB; Rick KRC; Fernando P; McKay BC
    PLoS One; 2020; 15(12):e0224953. PubMed ID: 33370278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alteration of the SETBP1 gene and splicing pathway genes SF3B1, U2AF1, and SRSF2 in childhood acute myeloid leukemia.
    Choi HW; Kim HR; Baek HJ; Kook H; Cho D; Shin JH; Suh SP; Ryang DW; Shin MG
    Ann Lab Med; 2015 Jan; 35(1):118-22. PubMed ID: 25553291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The compound cis-(dichloro)tetrammineruthenium(III) chloride induces caspase-mediated apoptosis in K562 cells.
    de Lima AP; Pereira Fde C; Vilanova-Costa CA; Mello FM; Ribeiro Ade S; Benfica PL; Valadares MC; Pavanin LA; dos Santos WB; Lacerda Ede P
    Toxicol In Vitro; 2010 Sep; 24(6):1562-8. PubMed ID: 20600797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of bufalin on up-regulating methylation of Wilm's tumor 1 gene in human erythroid leukemic cells.
    Wang LP; Zhao YN; Sun X; Gao RL
    Chin J Integr Med; 2017 Apr; 23(4):288-294. PubMed ID: 28364352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptotic events induced by synthetic naphthylchalcones in human acute leukemia cell lines.
    Maioral MF; Gaspar PC; Rosa Souza GR; Mascarello A; Chiaradia LD; Licínio MA; Moraes AC; Yunes RA; Nunes RJ; Santos-Silva MC
    Biochimie; 2013 Apr; 95(4):866-74. PubMed ID: 23257665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coherence between cellular responses and in vitro splicing inhibition for the anti-tumor drug pladienolide B and its analogs.
    Effenberger KA; Anderson DD; Bray WM; Prichard BE; Ma N; Adams MS; Ghosh AK; Jurica MS
    J Biol Chem; 2014 Jan; 289(4):1938-47. PubMed ID: 24302718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small Molecule TH-39 Potentially Targets Hec1/Nek2 Interaction and Exhibits Antitumor Efficacy in K562 Cells via G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Zhu Y; Wei W; Ye T; Liu Z; Liu L; Luo Y; Zhang L; Gao C; Wang N; Yu L
    Cell Physiol Biochem; 2016; 40(1-2):297-308. PubMed ID: 27855372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
    Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X
    Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ivermectin inhibits the growth of glioma cells by inducing cell cycle arrest and apoptosis in vitro and in vivo.
    Song D; Liang H; Qu B; Li Y; Liu J; Zhang Y; Li L; Hu L; Zhang X; Gao A
    J Cell Biochem; 2019 Jan; 120(1):622-633. PubMed ID: 30596403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.